ADD - Should the cost of Revlimid (lenalidomide) be reduced? - 101867

Spotlight
Video

ADD - Should the cost of Revlimid (lenalidomide) be reduced?

Loading........
Description: In this week’s video, Dr. Brian G.M. Durie addresses why the cost of patented drugs, such as Revlimid, have not yet been reduced.

BOTTOM LINE:
The cost of drugs is important to all of the myeloma community, and the IMF will continue to take part in discussing this.
Shared By : InternationalMyelomaFoundation
Posted on : 03/06/18
Added : 9 months ago
Category : Multiple Myeloma